Cargando…

Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer

Most patients with pancreatic cancer are ineligible for curative resection at diagnosis, resulting in poor prognosis. This study aimed to evaluate the prognostic factors in patients with unresectable pancreatic cancer. We retrospectively collected clinical data from 196 patients with unresectable pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terao, Takashi, Kumagi, Teru, Hyodo, Ichinosuke, Yokota, Tomoyuki, Azemoto, Nobuaki, Miyata, Hideki, Kuroda, Taira, Ohno, Yoshinori, Tanaka, Yoshinori, Shibata, Naozumi, Imamura, Yoshiki, Kanemitsu, Kozue, Miyake, Teruki, Koizumi, Mitsuhito, Hiasa, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556012/ https://www.ncbi.nlm.nih.gov/pubmed/34713835 http://dx.doi.org/10.1097/MD.0000000000027591

Ejemplares similares

Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
por: Kumagi, Teru, et al.
Publicado: (2023)

ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer
por: Tanaka, Yoshinori, et al.
Publicado: (2020)

Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients
por: Kuroda, Taira, et al.
Publicado: (2017)

Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids
por: Ohno, Yoshinori, et al.
Publicado: (2016)

Utility of Contrast-Enhanced Transabdominal Ultrasonography to Diagnose Early Chronic Pancreatitis
por: Azemoto, Nobuaki, et al.
Publicado: (2015)

Difficulty in management of intraductal papillary mucinous neoplasm-associated pancreatobiliary fistulas and the role of “pig-nose” appearance and intraductal ultrasonography in diagnosis
por: Koizumi, Mitsuhito, et al.
Publicado: (2016)

Diagnostic Challenge in Pancreatic Sarcoidosis Using Endoscopic Ultrasonography
por: Azemoto, Nobuaki, et al.
Publicado: (2017)

Endoscopic stent placement above the sphincter of Oddi for biliary strictures after living donor liver transplantation
por: Koizumi, Mitsuhito, et al.
Publicado: (2020)

Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer
por: Hino, Kaori, et al.
Publicado: (2022)

Apoptosis-associated speck-like protein containing a CARD regulates the growth of pancreatic ductal adenocarcinoma
por: Koizumi, Mitsuhito, et al.
Publicado: (2021)

Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients
por: Kuroda, Taira, et al.
Publicado: (2013)

Increased B Cell-Activating Factor Promotes Tumor Invasion and Metastasis in Human Pancreatic Cancer
por: Koizumi, Mitsuhito, et al.
Publicado: (2013)

Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma
por: Ohno, Yoshinori, et al.
Publicado: (2017)

Hyperuricemia Is a Risk Factor for the Onset of Impaired Fasting Glucose in Men with a High Plasma Glucose Level: A Community-Based Study
por: Miyake, Teruki, et al.
Publicado: (2014)

Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
por: Kanemitsu-Okada, Kozue, et al.
Publicado: (2023)

The Serum Creatinine Level Might Be Associated with the Onset of Impaired Fasting Glucose: A Community-based Longitudinal Cohort Health Checkup Study
por: Yoshida, Naohiko, et al.
Publicado: (2018)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

Relationship between urine pH and abnormal glucose tolerance in a community‐based study
por: Yoshida, Sakiko, et al.
Publicado: (2017)

Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study
por: Miyake, Teruki, et al.
Publicado: (2018)

TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma
por: Huang, Dexiao, et al.
Publicado: (2017)

Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study
por: Tang, Chengwu, et al.
Publicado: (2016)

HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Junguo, et al.
Publicado: (2022)

Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study
por: Okamoto, Masashi, et al.
Publicado: (2018)

Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma
por: Tsai, Wei-Lun, et al.
Publicado: (2020)

Partial response after treatment with Conversion chemotherapy: A case report of a patient with colon cancer and unresectable hepatic metastases
por: Bu, Zhaoting, et al.
Publicado: (2019)

High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma
por: Song, Peipei, et al.
Publicado: (2015)

Infection as a Risk Factor in the Pathogenesis of Primary Biliary Cirrhosis: Pros and Cons
por: Kumagi, Teru, et al.
Publicado: (2010)

Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study
por: Miyake, Teruki, et al.
Publicado: (2022)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Serum zinc concentration and quality of life in chronic liver diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2019)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease
por: Takata, Ryo, et al.
Publicado: (2017)

Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices
por: Sakai, Yoshiyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8c1n0g8sr18mgcvusgkh453h6j